Literature DB >> 20425290

Anticoagulation and psychotropic medications.

Maurice Bachawati1.   

Abstract

Anticoagulants and psychotropic medications are commonly prescribed together. Thus, the potential for interaction exists. Whereas thrombolytics and heparins are implicated in few pharmacokinetic interactions, warfarin and platelet inhibitors have been implicated in various interactions with psychotropic medications. In this article, I review the various psychotropic drug classes' relationships to anticoagulants. In a field devoid of randomized, placebo-controlled trials, clinical vigilance is advised when managing patients on concomitant therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425290     DOI: 10.1007/s11920-010-0120-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  48 in total

1.  Acquired haemophilia in recipients of depot thioxanthenes.

Authors:  A J Stewart; L M Manson; H Dasani; A Beddall; P Collins; M Shima; C A Ludlam
Journal:  Haemophilia       Date:  2000-11       Impact factor: 4.287

2.  Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis.

Authors:  S Wessinger; M Kaplan; L Choi; M Williams; C Lau; L Sharp; M D Crowell; A Keshavarzian; M P Jones
Journal:  Aliment Pharmacol Ther       Date:  2006-04-01       Impact factor: 8.171

Review 3.  Thrombolytics: drug interactions of clinical significance.

Authors:  S Harder; U Klinkhardt
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

4.  The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.

Authors:  P J Tiseo; K Foley; L T Friedhoff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 5.  Clinically relevant drug interactions with antiepileptic drugs.

Authors:  Emilio Perucca
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

6.  Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study.

Authors:  Xavier Vidal; Luisa Ibáñez; Lourdes Vendrell; Ana Conforti; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).

Authors:  Neda Tavassoli; Agnes Sommet; Maryse Lapeyre-Mestre; Haleh Bagheri; Jean-Louis Montrastruc
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

8.  Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.

Authors:  John-Michael Sauer; Amanda J Long; Barbara Ring; Jennifer S Gillespie; Nathan P Sanburn; Karl A DeSante; David Petullo; Mark R VandenBranden; Charles B Jensen; Steven A Wrighton; Brian P Smith; Holly A Read; Jennifer W Witcher
Journal:  J Pharmacol Exp Ther       Date:  2003-11-10       Impact factor: 4.030

Review 9.  New antithrombotic drugs.

Authors:  P L Gross; J I Weitz
Journal:  Clin Pharmacol Ther       Date:  2009-06-24       Impact factor: 6.875

10.  Warfarin and Antidepressants: Happiness without Hemorrhaging.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-07
View more
  2 in total

1.  DeepBiomarker: Identifying Important Lab Tests from Electronic Medical Records for the Prediction of Suicide-Related Events among PTSD Patients.

Authors:  Oshin Miranda; Peihao Fan; Xiguang Qi; Zeshui Yu; Jian Ying; Haohan Wang; David A Brent; Jonathan C Silverstein; Yu Chen; Lirong Wang
Journal:  J Pers Med       Date:  2022-03-24

Review 2.  The critical interaction between valproate sodium and warfarin: case report and review.

Authors:  Chenguang Zhou; Yi Sui; Weijin Zhao; Chunyao Dong; Li Ren; Pingmei Song; Bing Xu; Xiaohong Sun
Journal:  BMC Pharmacol Toxicol       Date:  2018-10-01       Impact factor: 2.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.